This Probiotic Cut Gut Transit Time by 29 Hours in 4 Weeks
November 16, 2026Best Urolithin A in Canada (2026)
November 17, 2026Quick Summary
A new randomized trial from the University of Oklahoma gave 50 adults with obesity either 1,000 mg of urolithin A or a placebo every day for four weeks. Brain scans showed the supplement group sent significantly more blood to the brain’s working-memory centre during a tough memory task. But their memory scores didn’t improve, and arm blood-vessel function didn’t change.
Picture this: you swallow a capsule of a compound your gut normally brews from pomegranates, and four weeks later your brain pulls in measurably more blood every time you concentrate. That is what University of Oklahoma researchers just reported in JAMA Network Open — the first human trial to test urolithin A on the brain’s blood supply. The catch? The extra blood flow didn’t make anyone’s memory better. Not yet, anyway.
| Topic | What the research shows |
|---|---|
| The trial | 50 adults aged 40–64 with obesity (mean BMI 38.3), randomized to 1,000 mg urolithin A or placebo daily for 4 weeks |
| Brain blood flow | Significantly greater blood-flow response in the left dorsolateral prefrontal cortex during a memory task (β 15.53 vs −1.43 for placebo) |
| Memory scores | No significant improvement — most participants were already scoring near-perfect, a likely ceiling effect |
| Arm blood vessels | No significant change in flow-mediated dilation, the trial’s main outcome (P = .33) |
| Safety | Well tolerated; headache was the most common side effect, reported by 3 people on urolithin A and 6 on placebo |
More Blood to the Brain — But Only When It Was Working Hard
The researchers weren’t testing whether urolithin A makes you smarter. They were testing plumbing. When your brain tackles a hard problem, it needs more oxygen and nutrients, so blood flow to the active region should rise on demand. In people with obesity, that response can be blunted.
To measure it, the team used functional near-infrared spectroscopy, a cap of light sensors that tracks blood flow in the brain’s outer layers while volunteers worked through a memory challenge called the N-back task. After four weeks, the urolithin A group showed a significantly stronger blood-flow response in the left dorsolateral prefrontal cortex — the brain’s working-memory hub — compared with placebo. The response score (a β coefficient) averaged 15.53 in the supplement group and −1.43 in the placebo group. Lead author Ana Clara da Costa Pinaffi Langley put it simply: the supplement may help the brain meet its increased need for oxygen and nutrients when it is working harder.
The Twist: Memory Didn’t Budge
Despite the extra blood flow, nobody in the supplement group performed better on the memory tests than anyone on placebo. Reaction times and accuracy were essentially the same in both groups.
Before you write the whole thing off, consider the catch the researchers flagged: most volunteers were already acing the tests before the trial started. On the attention task, 94% had perfect scores at baseline, and a third were perfect on the working-memory task too. When everyone starts at the top of the scale, there is nowhere left to climb — scientists call this a ceiling effect. Future trials will need harder tasks, or volunteers whose memory is already slipping.
And the trial’s main outcome — blood-vessel function in the arm, measured by flow-mediated dilation — also missed. The supplement group improved by 1.3% and the placebo group by 0.3%, a difference that was not statistically significant (P = .33). The authors suggest four weeks, or the 1,000 mg dose, may have been too short or too small to move the arm’s vessels — and that the brain effect may run through a different mechanism, possibly related to inflammation in the nervous system.
Why This Trial Matters Anyway
Small study, mixed results — so why should you care? First, it is a first: no human trial had ever looked at urolithin A and brain blood flow before. The supplement has spent years building a reputation around muscle and mitochondria, and this trial opens a whole new front: the brain. Second, the design was solid: double-blind and placebo-controlled, 25 people in each group, adherence over 95% in both arms, funded by the American Heart Association and the Reynolds Foundation, with no conflicts of interest reported. Not a company-funded marketing exercise.
Third, the brain finding fits a pattern. In a 2022 trial of 66 adults aged 65 to 90, 1,000 mg a day for four months improved muscle endurance at two months. In another 2022 trial — run in Ontario, Canada, in 88 sedentary adults aged 40 to 64 — hamstring strength rose by about 12% on urolithin A while it fell by about 10% on placebo. Yet in both, the main outcome missed. Urolithin A keeps producing intriguing side findings while its headline goals slip away — a supplement worth watching, not one worth overselling.
What Is Urolithin A and How Is It Supposed to Work?
Urolithin A is not something you eat directly. It is made inside you: certain gut bacteria convert compounds called ellagitannins — found in pomegranates, strawberries, walnuts and raspberries — into urolithin A. The snag is that not everyone makes it well: your ability to produce it drops with age and with higher body weight, which is one reason a supplement is attractive — it delivers the compound directly, no gut-bacteria lottery required.
Once in the body, urolithin A is best known as a mitophagy activator — a fancy way of saying it may help cells clear out old, damaged mitochondria, the tiny power plants inside your cells, and recycle them. Mitochondria wear out with age, and sluggish mitochondria have been linked to weaker blood vessels and poorer brain function. This trial is the first human evidence that the brain’s blood supply might be part of the story.
What Are the Side Effects of Urolithin A?
So far, the safety record looks calm. In this trial, 22 of the 50 participants reported a total of 43 adverse events, split evenly between the groups. The most common complaint was headache, reported by 6 people on placebo and 3 on the supplement. In other words, side effects looked no worse than a sugar pill.
That matches the broader record: across the human trials published so far, side effects on urolithin A have looked similar to placebo, and the compound has been tested at doses up to 2,000 mg a day and for as long as four months. Still, the evidence base is small — published trials have enrolled only 10 to 88 people each — and there is little data on use beyond four months. People who are pregnant or nursing, or who take medication, should talk to a healthcare professional first.
How Much Urolithin A Should You Take?
The honest answer is that nobody knows the ideal dose yet, because no trial has been designed to find it. The doses used in human research so far are 500 mg and 1,000 mg a day. This brain trial used 1,000 mg a day, split into two daily doses of 500 mg, for four weeks. The muscle trials used the same 1,000 mg dose for four months, and one also tested 500 mg.
More is not automatically better. The paper notes that urolithin A has been shown safe at up to 2,000 mg a day, but no study has shown a higher dose works better. Until longer trials test doses head to head, the research-backed range is 500 to 1,000 mg a day.
What Should You Look For on the Label?
Urolithin A is a newer ingredient. A few things to check before buying. First, the dose on the label should match the research: 500 or 1,000 mg of urolithin A per daily serving, stated plainly — not buried inside a proprietary blend where you can’t tell how much you’re actually getting. Second, look for third-party testing: independent verification that the bottle contains what the label claims matters more for a newer ingredient. Third, if you’re shopping in Canada, check for a valid eight-digit Natural Product Number (NPN) on the label — an NPN means Health Canada has reviewed the product for safety, quality and the claims on its label.
And be wary of brain-health promises. This trial found a blood-flow signal, not a memory benefit. Any product claiming it will sharpen your memory is getting ahead of the science.
References
- da Costa Pinaffi-Langley, A. C., et al. (2026). Urolithin A and Endothelial and Cerebrovascular Function in Middle-Aged Adults With Obesity: A Randomized Clinical Trial. JAMA Network Open. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2855121
- Liu, S., et al. (2022). Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Network Open, 5(1), e2144279. https://pmc.ncbi.nlm.nih.gov/articles/PMC8777576/
- Singh, A., et al. (2022). Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Reports Medicine, 3, 100633. https://doi.org/10.1016/j.xcrm.2022.100633
- University of Oklahoma Health Sciences. (2026, November 11). Clinical Trial Explores Potential Brain Health Benefits of Dietary Supplement. https://www.ouhsc.edu/news/details/clinical-trial-explores-potential-brain-health-benefits-of-dietary-supplement
This article reports on recent health research and is for general information only — it isn’t medical advice and doesn’t replace your doctor, pharmacist, or another qualified professional. Study findings describe what researchers observed, not a promise of results, and nothing here claims any supplement can diagnose, treat, cure, or prevent a disease. These statements have not been evaluated by Health Canada. Check with a healthcare professional before starting any new supplement, especially if you’re pregnant, nursing, taking medication, or managing a health condition.
